Manulife (Manufacturers Life Insurance)
PCVX icon

Manulife (Manufacturers Life Insurance)’s Vaxcyte PCVX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31M Buy
108,504
+22,138
+26% +$1.2M ﹤0.01% 1101
2026
Q1 		$5.02M Sell
86,366
-22,079
-20% -$1.2M ﹤0.01% 1161
2025
Q4 		$4.97M Sell
108,445
-28,425
-21% -$1.27M ﹤0.01% 1169
2025
Q3 		$4.93M Sell
136,870
-71,140
-34% -$2.36M ﹤0.01% 1178
2025
Q2 		$6.76M Buy
208,010
+54,858
+36% +$1.8M 0.01% 1026
2025
Q1 		$5.78M Sell
153,152
-5,376
-3% -$430K 0.01% 1109
2024
Q4 		$13M Buy
158,528
+1,504
+1% +$149K 0.01% 761
2024
Q3 		$17.9M Buy
157,024
+25,275
+19% +$2.28M 0.02% 665
2024
Q2 		$9.95M Buy
131,749
+12,667
+11% +$862K 0.01% 843
2024
Q1 		$8.13M Buy
119,082
+14,009
+13% +$970K 0.01% 957
2023
Q4 		$6.6M Buy
105,073
+12,249
+13% +$636K ﹤0.01% 1041
2023
Q3 		$4.73M Buy
92,824
+11,135
+14% +$549K ﹤0.01% 1139
2023
Q2 		$4.08M Buy
81,689
+52,729
+182% +$2.5M ﹤0.01% 1185
2023
Q1 		$1.09M Buy
28,960
+463
+2% +$19.6K ﹤0.01% 1596
2022
Q4 		$1.37M Buy
28,497
+7,754
+37% +$304K ﹤0.01% 1490
2022
Q3 		$498K Sell
20,743
-13
-0.1% -$330 ﹤0.01% 1975
2022
Q2 		$452K Buy
20,756
+3,247
+19% +$75.1K ﹤0.01% 2118
2022
Q1 		$423K Sell
17,509
-3,971
-18% -$86.8K ﹤0.01% 2296
2021
Q4 		$511K Buy
21,480
+101
+0.5% +$2.35K ﹤0.01% 2241
2021
Q3 		$542K Sell
21,379
-1,509
-7% -$36.6K ﹤0.01% 2230
2021
Q2 		$515K Buy
22,888
+6,249
+38% +$128K ﹤0.01% 2405
2021
Q1 		$329K Buy
16,639
+5,379
+48% +$135K ﹤0.01% 2555
2020
Q4 		$299K Buy
11,260
+1,297
+13% +$48.2K ﹤0.01% 2520
2020
Q3 		$492K Buy
+9,963
New +$397K ﹤0.01% 2010

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PCVX Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Vaxcyte (PCVX) stake by 26% in Q2 2026, buying an estimated $1.2M and bringing the position to 108,504 shares worth $6.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Manulife (Manufacturers Life Insurance) first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. The position peaked at $17.9M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 108,504 shares of Vaxcyte worth $6.31M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 22,138 Vaxcyte shares in Q2 2026, an estimated $1.2M.
  • Vaxcyte made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1101 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Vaxcyte position peaked at $17.9M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.